Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Vaxcyte Inc fell by 436.97m. Cash Flow from Financing totalled 639.81m or -- of revenues. In addition the company used 296.79m for operations while cash used for investing totalled 773.31m.
Cash flow per share | -4.42 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 27.47 |
---|---|
Tangible book value per share | 27.47 |
More ▼
Balance sheet in USDView more
Current ratio | 17.88 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼